BerandaZLDPF • OTCMKTS
add
Zealand Pharma A/S
Tutup sebelumnya
$101,61
Rentang hari
$104,05 - $104,05
Rentang tahun
$47,92 - $141,74
Kapitalisasi pasar
7,35Â M USD
Volume Rata-Rata
1,95Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (DKK) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 4,42Â jt | -98,51% |
Biaya operasional | 360,45Â jt | 47,08% |
Laba bersih | -266,40Â jt | -459,29% |
Margin laba bersih | -6,03Â rb | -24.148,94% |
Penghasilan per saham | -3,77 | -406,50% |
EBITDA | -343,22Â jt | -793,69% |
Tarif pajak efektif | 0,51% | — |
Neraca
Total aset
Total liabilitas
| (DKK) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 8,48Â M | 436,03% |
Total aset | 9,63Â M | 342,65% |
Total liabilitas | 746,69Â jt | 108,16% |
Total ekuitas | 8,88 M | — |
Saham yang beredar | 70,65 jt | — |
Harga terhadap nilai buku | 0,81 | — |
Tingkat pengembalian aset | -8,83% | — |
Tingkat pengembalian modal | -9,17% | — |
Arus Kas
Perubahan kas bersih
| (DKK) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -266,40Â jt | -459,29% |
Kas dari operasi | -295,33Â jt | -162,05% |
Kas dari investasi | -6,07Â M | -3.892,89% |
Kas dari pembiayaan | -272,24Â jt | -6.851,93% |
Perubahan kas bersih | -6,64Â M | -11.806,98% |
Arus kas bebas | -238,27Â jt | -53,42% |
Tentang
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
Didirikan
1 Apr 1997
Situs
Karyawan
298
